Literature DB >> 9228537

Evidence for bradykinin B2-receptors on cultured human decidua cells.

J Rehbock1, A Chondromatidou, K Miska, P Buchinger, A Hermann.   

Abstract

Bradykinin is known to be present at sites of acute inflammation and to exert its potent inflammatory effects mainly via the bradykinin B2-receptor. Recently, bradykinin dependent processes have been described in cultured human decidual cells, so that bradykinin may expand the list of paracrine factors involved in labour induction. In this paper we present the results of in vitro studies giving evidence that these cells carry the bradykinin B2-receptor. By immunocytochemical methods the receptor protein was localized on decidual cells. Analysis of cellular extracts of cultured decidual cells by RT-PCR showed the presence of the specific mRNA coding for the bradykinin B2-receptor. Binding studies revealed a single, saturable and specific binding site for bradykinin of high affinity (Kd = 0.85 nM, Bmax = 436 fmol/mg protein). Competitive binding studies showed displacement of [3H]-bradykinin by HOE 140, but not by the ligands for the bradykinin B1-receptor, des-Arg10-kallidin and [Leu8]-des-Arg9-bradykinin. The results are consistent with the presence of the bradykinin B2-receptors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9228537     DOI: 10.1016/s0162-3109(97)00012-x

Source DB:  PubMed          Journal:  Immunopharmacology        ISSN: 0162-3109


  3 in total

1.  Tissue kallikrein in human placenta in early and late gestation.

Authors:  G Valdés; C Chacón; J Corthorn; C D Figueroa; A M Germain
Journal:  Endocrine       Date:  2001-03       Impact factor: 3.633

2.  Tissue kallikrein and bradykinin B2 receptor in human uterus in luteal phase and in early and late gestation.

Authors:  G Valdés; A M Germain; J Corthorn; C Chacón; C D Figueroa; W Müller-Esterl
Journal:  Endocrine       Date:  2001-12       Impact factor: 3.633

3.  Multiple doses of icatibant used during pregnancy.

Authors:  Lauren W Kaminsky; Theodore Kelbel; Fay Ansary; Timothy Craig
Journal:  Allergy Rhinol (Providence)       Date:  2017-10-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.